dbACP: A Comprehensive Database of Anti-Cancer Peptides

29 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp06724 L14 ALWKSILKNAGKALNEINQIVQ Dermaseptin-SS1- Analog Membrane Permeabilization MTT assay H-460 Lung Cancer IC50 = 20.1 µM
dbacp06726 14V ALWKSILKNAGKAVLNEINQIVQ Dermaseptin-SS1- Analog Membrane Permeabilization MTT assay H-460 Lung Cancer IC50 = 4.1 µM
dbacp06728 14G ALWKSILKNAGKAGLNEINQIVQ Dermaseptin-SS1- Analog Membrane Permeabilization MTT assay H-460 Lung Cancer IC50 = 31.7 µM
dbacp06730 L2V ALWKSILKNVGKVLNEINQIVQ Dermaseptin-SS1- Analog Membrane Permeabilization MTT assay H-460 Lung Cancer IC50 = 0.6 µM
dbacp06732 14V5K ALWKKILKNAGKAVLNEINQIVQ Dermaseptin-SS1- Analog Membrane Permeabilization MTT assay H-460 Lung Cancer IC50 = 6.1 µM
dbacp06734 14VL23 ALWKSILKNAGKAVLNEINQIV Dermaseptin-SS1- Analog Membrane Permeabilization MTT assay H-460 Lung Cancer IC50 = 16.4 µM
dbacp06801 A11 EYVQTVKSSKG Annexin A1 Targeting PD-L2 Biotin Pull Down assay H-460 Lung Cancer Not Available
dbacp06903 CIGB-300 GRKKRRQRRRPPQ-X-CWMSPRHLGTC Synthetic Cell Penetration Crystal Violet assay NCI-H-460 Lung Cancer IC50 = 30 ± 5.3 µM
dbacp06914 AC-P19M FAKKLAKLKKKLAKLAKKR Synthetic analogue of AC-P19 Inhibition of cell signalling WST-8 assay H-460 Lung Cancer IC50 = 6.29 µM
dbacp06916 AC-P19 FAKKLAKLKKKLAKLALAL Synthetic Inhibition of cell signalling WST-8 assay H-460 Lung Cancer IC50 = 49.08 µM
dbacp06942 HTDT-6-2-3-2 GPLGAGP Enteromorpha prolifera Apoptosis inducing CCK-8 assay NCI-H-460 Lung Cancer IC50 = 0.3686 ± 0.0935 mg/mL
dbacp07102 rScyreprocin MKEDSNILDKTAKMTKQNKALLFTAGGAAAFMAGYYYYHCNYRNPAPKKSGSTTSQDKTDAQAVQSIPSPSGNKGKESKDPKVKHHHHHH Recombinant product of Scyreprocin Membrane disruption triggers ROS-mediated apoptosis MTS assay H-460 Lung Cancer IC50 = 6.27 µM
dbacp07244 CIGB-552 HARIKpTFRRlKWKYKGKFW Synthetic NF-κB inhibition enhances cisplatin synergy Sulforhodamine B assay NCI-H-460 Lung Cancer IC50 = 287.9 μM
dbacp07338 Temporin-HLa FFPLIFGALSSILPKIL Hylarana latouchii Membrane disruption MTT assay H-460 Lung Cancer IC50 = 1.64 ± 0.41 μM
dbacp07467 Tachyplesin KWCFRVCYRGICYIRRCR Horseshoe crab Fas activation drives apoptosis/necroptosis MTT assay H-460 Lung Cancer IC50 = 25 µg/ml
dbacp07644 Colicin N HGDNNSKPKPGGNSGNRGNNGDGASAKVGEITITPDNSKPGRYISSNPEYSLLAKLIDAESIKGTEVYTFHTRKGQYVKVTVPDSNIDKMRVDYVNWKGPKYNNKLVKRFVSQFLLFRKEEKEKNEKEALLKASELVSGMGDKLGEYLGVKYKNVAKEVANDIKNFHGRNIRSYNEAMASLNKVLANPKMKVNKSDKDAIVNAWKQVNAKDMANKIGNLGKAFKVADLAIKVEKIREKSIEGYNTGNWGPLLLEVESWIIGGVVAGVAISLFGAVLSFLPISGLAVTALGVIGIMTISYLSSFIDANRVSNINNIISSVIR Apoptosis via integrin-Akt suppression MTT assay H-460 Lung Cancer Dose dependent % cell viability resuctuction at 1-15 µM
dbacp07867 R-Lycosin I derivative 8a RGWFRAMRSIARFIARERLRGHL Monosaccharide Analogue of Anticancer Peptide R-Lycosin-I GLUT1-mediated uptake enhances cytotoxicity CCK-8 assay H-460 Lung Cancer IC50 = 8.5 ± 0.4 µM
dbacp07873 R-Lycosin I derivative 8b RGWFRAMRSIARFIARERLRGHL Monosaccharide Analogue of Anticancer Peptide R-Lycosin-I GLUT1-mediated uptake enhances cytotoxicity CCK-8 assay H-460 Lung Cancer IC50 = 4.9 ± 0.9 µM
dbacp07877 Fi-Histin1-21 SRSSRAGLQFPVGRIHRLLRK Fenneropenaeus indicus Membrane disruption and DNA binding XTT assay NCI-H-460 Lung Cancer IC50 = 22.670 ± 13.939 μM
dbacp07995 [G10a]SHa FLSGIVGMLaKLF Synthetic analogue of Temporin-1SHa Enhanced cationicity/hydrophobicity increases cytotoxicity MTT assay NCI-H-460 Lung Cancer IC50 =24.3 ± 0.8 µM
dbacp07998 [G10a]SHa-BCTP FLSGIVGMLaKLFLFKQYAELW Synthetic analogue of Temporin-1SHa Enhanced cationicity/hydrophobicity increases cytotoxicity MTT assay NCI-H-460 Lung Cancer IC50 >100 µM
dbacp08001 [G4a]SHa FLSaIVGMLGKLF Synthetic analogue of Temporin-1SHa Enhanced cationicity/hydrophobicity increases cytotoxicity MTT assay NCI-H-460 Lung Cancer IC50 >100 µM
dbacp08004 [G7a]SHa FLSGIVaMLGKLF Synthetic analogue of Temporin-1SHa Enhanced cationicity/hydrophobicity increases cytotoxicity MTT assay NCI-H-460 Lung Cancer IC50 >100 µM
dbacp08007 [G4,7a]SHa FLSaIVaMLGKLF Synthetic analogue of Temporin-1SHa Enhanced cationicity/hydrophobicity increases cytotoxicity MTT assay NCI-H-460 Lung Cancer IC50 = 37.3 ± 3.5 µM
dbacp08010 [G4,7,10a]SHa FLSaIVaMLaKLF Synthetic analogue of Temporin-1SHa Enhanced cationicity/hydrophobicity increases cytotoxicity MTT assay NCI-H-460 Lung Cancer IC50 >100 µM
dbacp08013 [G7,10a]SHa FLSGIVaMLaKLF Synthetic analogue of Temporin-1SHa Enhanced cationicity/hydrophobicity increases cytotoxicity MTT assay NCI-H-460 Lung Cancer IC50 >100 µM
dbacp08016 Ec-LDP-hBD1 MANCVVGYIGERCQYRDLKWWELRGGGGSGGGGSAPAFSVSPASGLSDGQSVSVSVSGAAAGETYYIAQCAPVGGQDACNPATATSFTTDASGAASFSFVVRKSYTGSTPEGTPVGSVDCATAACNLGAGNSGLDLGHVALTFGGGGGSGGGGSDHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCKLEHHHHHH Synthetic EGFR-targeted defensin induces mitochondrial apoptosis CCK-8 assay H-460 Lung Cancer IC50 = 5.19 μM
dbacp08039 Silk Fibroin peptide Not Available Silkworm Cocoons SFP induces S-phase cell-cycle arrest MTT assay H-460 Lung Cancer IC50 = 9.083 ± 1.22 mg/ml
dbacp08360 Seq ID No. 26 from patent ID US202000079827A1 RRWVRRVRRVWRRVVRVVRRWVRR Synthetic Not Available Tetrazolium-based assay H-460 Lung Cancer Cell viability < 50% at 20 μM